Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2021 | 4 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
BTK Inhibitors in Chronic Lymphocytic Leukemia: Biological Activity and Immune Effects.
Front Immunol. 2021 Jul 1;12:686768. doi: 10.3389/fimmu.2021.686768. eCollection 2021.
Front Immunol. 2021.
PMID: 34276674
Free PMC article.
Review.
Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application.
Mulder TA, Wahlin BE, Österborg A, Palma M.
Mulder TA, et al.
Cancers (Basel). 2019 Jun 29;11(7):915. doi: 10.3390/cancers11070915.
Cancers (Basel). 2019.
PMID: 31261914
Free PMC article.
Review.
Item in Clipboard
Immune Biomarkers in the Peripheral Blood and Tumor Microenvironment of Classical Hodgkin Lymphoma Patients in Relation to Tumor Burden and Response to Treatment.
Mulder TA, Andersson ML, Peña-Pérez L, Heimersson K, Xagoraris I, Wahlin BE, Månsson R, Hansson L, Rassidakis G, Palma M.
Mulder TA, et al.
Hemasphere. 2022 Oct 26;6(11):e794. doi: 10.1097/HS9.0000000000000794. eCollection 2022 Nov.
Hemasphere. 2022.
PMID: 36325271
Free PMC article.
Item in Clipboard
Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients.
Van Wigcheren GF, De Haas N, Mulder TA, Horrevorts SK, Bloemendal M, Hins-Debree S, Mao Y, Kiessling R, van Herpen CML, Flórez-Grau G, Hato SV, De Vries IJM.
Van Wigcheren GF, et al. Among authors: mulder ta.
Oncoimmunology. 2021 Jun 27;10(1):1935557. doi: 10.1080/2162402X.2021.1935557. eCollection 2021.
Oncoimmunology. 2021.
PMID: 34239773
Free PMC article.
Item in Clipboard
Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients.
Palma M, Hansson L, Mulder TA, Adamson L, Näsman-Glaser B, Eriksson I, Heimersson K, Ryblom H, Mozaffari F, Svensson A, Gentilcore G, Österborg A, Mellstedt H.
Palma M, et al. Among authors: mulder ta.
Eur J Haematol. 2018 Jul;101(1):68-77. doi: 10.1111/ejh.13065. Epub 2018 May 22.
Eur J Haematol. 2018.
PMID: 29569742
Clinical Trial.
Item in Clipboard
Temporary cessation of ibrutinib results in reduced grade 3-4 infections and durable remissions-Interim analysis of an on-off-repeat Phase 1b/2 study in patients with chronic lymphocytic leukemia.
Lundin J, Mulder TA, Kättström M, Wästerlid T, Uddevik A, Mellstedt H, Heimersson K, Hansson L, Palma M, Österborg A.
Lundin J, et al. Among authors: mulder ta.
EJHaem. 2021 Jul 14;2(3):525-529. doi: 10.1002/jha2.261. eCollection 2021 Aug.
EJHaem. 2021.
PMID: 35844699
Free PMC article.
Item in Clipboard
Ibrutinib Has Time-dependent On- and Off-target Effects on Plasma Biomarkers and Immune Cells in Chronic Lymphocytic Leukemia.
Mulder TA, Peña-Pérez L, Berglöf A, Meinke S, Estupiñán HY, Heimersson K, Zain R, Månsson R, Smith CIE, Palma M.
Mulder TA, et al.
Hemasphere. 2021 Apr 26;5(5):e564. doi: 10.1097/HS9.0000000000000564. eCollection 2021 May.
Hemasphere. 2021.
PMID: 33912812
Free PMC article.
Item in Clipboard
Cite
Cite